Literature DB >> 28912175

In vitro evidence of complement activation in patients with sickle cell disease.

Eleni Gavriilaki1, Maria Mainou2, Ioanna Christodoulou2, Eudoxia-Evaggelia Koravou3, Aggeliki Paleta3, Tasoula Touloumenidou3, Apostolia Papalexandri3, Anastasia Athanasiadou3, Chrysa Apostolou2, Philippos Klonizakis2, Achilles Anagnostopoulos3, Efthymia Vlachaki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28912175      PMCID： PMC5709116          DOI： 10.3324/haematol.2017.174201

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.

Authors:  Arthur J Vaught; Eleni Gavriilaki; Nancy Hueppchen; Karin Blakemore; Xuan Yuan; Sara M Seifert; Sarah York; Robert A Brodsky
Journal:  Exp Hematol       Date:  2016-02-26       Impact factor: 3.084

2.  Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.

Authors:  Yann Lamarre; Marc Romana; Xavier Waltz; Marie-Laure Lalanne-Mistrih; Benoît Tressières; Lydia Divialle-Doumdo; Marie-Dominique Hardy-Dessources; Jens Vent-Schmidt; Marie Petras; Cedric Broquere; Frederic Maillard; Vanessa Tarer; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

3.  Modified Ham test for atypical hemolytic uremic syndrome.

Authors:  Eleni Gavriilaki; Xuan Yuan; Zhaohui Ye; Alexander J Ambinder; Satish P Shanbhag; Michael B Streiff; Thomas S Kickler; Alison R Moliterno; C John Sperati; Robert A Brodsky
Journal:  Blood       Date:  2015-04-10       Impact factor: 22.113

4.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 5.  Transplant-associated thrombotic microangiopathy: opening Pandora's box.

Authors:  E Gavriilaki; I Sakellari; A Anagnostopoulos; R A Brodsky
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

6.  Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation.

Authors:  S T Test; V S Woolworth
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

7.  Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

Authors:  Marie Frimat; Fanny Tabarin; Jordan D Dimitrov; Caroline Poitou; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Blood       Date:  2013-05-21       Impact factor: 22.113

8.  Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

Authors:  Spero R Cataland; V Michael Holers; Susan Geyer; Shangbin Yang; Haifeng M Wu
Journal:  Blood       Date:  2014-04-02       Impact factor: 22.113

9.  Typical Hus: Evidence of Acute Phase Complement Activation from a Daycare Outbreak.

Authors:  Tammy M Brady; Cozumel Pruette; Lauren F Loeffler; Darcy Weidemann; John J Strouse; Eleni Gavriilaki; Robert A Brodsky
Journal:  J Clin Exp Nephrol       Date:  2016-05-06

10.  Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.

Authors:  Poulami Maitra; Melissa Caughey; Laura Robinson; Payal C Desai; Susan Jones; Mehdi Nouraie; Mark T Gladwin; Alan Hinderliter; Jianwen Cai; Kenneth I Ataga
Journal:  Haematologica       Date:  2017-01-19       Impact factor: 9.941
View more
  8 in total

1.  Critical role of C5a in sickle cell disease.

Authors:  Gregory M Vercellotti; Agustin P Dalmasso; Terry R Schaid; Julia Nguyen; Chunsheng Chen; Marna E Ericson; Fuad Abdulla; Trevor Killeen; Margaret A Lindorfer; Ronald P Taylor; John D Belcher
Journal:  Am J Hematol       Date:  2019-01-03       Impact factor: 10.047

2.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

3.  Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule.

Authors:  Elisabetta Lombardi; Alessandro Matte; Antonio M Risitano; Daniel Ricklin; John D Lambris; Denise De Zanet; Sakari T Jokiranta; Nicola Martinelli; Cinzia Scambi; Gianluca Salvagno; Zeno Bisoffi; Chiara Colato; Angela Siciliano; Oscar Bortolami; Mario Mazzuccato; Francesco Zorzi; Luigi De Marco; Lucia De Franceschi
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 4.  Complement in Sickle Cell Disease: Are We Ready for Prime Time?

Authors:  Eleni Gavriilaki; Efthymia Vlachaki; Christos Varelas; Athina Tampaki; Ioanna Sakellari; Αchilles Anagnostopoulos
Journal:  J Blood Med       Date:  2021-03-23

5.  Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.

Authors:  Alexander Leonardo Silva-Junior; Nadja Pinto Garcia; Evilázio Cunha Cardoso; Stephanny Dias; Andrea Monteiro Tarragô; Nelson Abrahim Fraiji; Matheus Souza Gomes; Laurence Rodrigues Amaral; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Erich Vinicius De Paula; Allyson Guimarães Costa; Adriana Malheiro
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

6.  Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center.

Authors:  Christos Varelas; Eleni Gavriilaki; Ioanna Sakellari; Philippos Klonizakis; Evaggelia-Evdoxia Koravou; Ioanna Christodoulou; Ioulia Mavrikou; Andreas Kourelis; Fani Chatzopoulou; Dimitrios Chatzidimitriou; Tasoula Touloumenidou; Apostolia Papalexandri; Achilles Anagnostopoulos; Efthimia Vlachaki
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

Review 7.  The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.

Authors:  Elie Nader; Marc Romana; Philippe Connes
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

8.  Genetic modifiers of long-term survival in sickle cell anemia.

Authors:  Ambroise Wonkam; Emile R Chimusa; Khuthala Mnika; Gift Dineo Pule; Valentina Josiane Ngo Bitoungui; Nicola Mulder; Daniel Shriner; Charles N Rotimi; Adebowale Adeyemo
Journal:  Clin Transl Med       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.